Eliquis and plavix combination therapy

Similar documents
Plavix eliquis and aspirin

TRIPLE THERAPY, NOACs with concurrent indication for DAPT. Paul Wright Lead Cardiac Pharmacist The Heart, UCLH NHS Foundation Trust

When and how to combine antiplatelet agents and anticoagulant?

Xarelto and plavix taken together.

Antiplatelet and Anti-Thrombotic Therapy. Ivan Anderson, MD RIHVH Cardiology

The Challenge. Warfarin or Novel Oral Anti-Coagulants in the PCI patient? Anticoagulation/Stroke

Asif Serajian DO FACC FSCAI

UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES

Management of Patients with Atrial Fibrillation and Stents: Is Three Drugs Too Many?

Stable CAD, Elective Stenting and AFib

Antiplatelets and Anticoagulants. Helen Leung, PharmD PGY1 Pharmacy Resident Memorial Hermann-Texas Medical Center

Special Conditions of NOAC PCI 가톨릭의대 순환기내과 장성원

DIRECT ORAL ANTICOAGULANTS

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS

PCI in Patients with AF Optimizing Oral Anticoagulation Regimen

Which drug do you prefer for stable CAD? - P2Y12 inhibitor

The Poor Long-Term Candidate for Warfarin: NOAC or Left Atrial Appendage Closure?

Bleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM

Optimal lenght of DAPT in different clinical scenarios

Triple Therapy: A review of the evidence in acute coronary syndrome. Stephanie Kling, PharmD, BCPS Sanford Health

Anti-thromboticthrombotic drugs

Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

The Korean Society of Cardiology COI Disclosure

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

GLORIA -AF REGISTRY PROGRAMME

INR as a Biomarker: Anticoagulation in Atrial Fib, Heart Failure, and Cardiovascular Disease Daniel Blanchard, MD, FACC, FAHA

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

Triple Therapy After PCI in AF: A Quagmire Soon to be Drained

NAVIGATING THROMBOSIS AND BLEEDING AT THE INTERSECTION OF ATRIAL FIBRILLATION AND CORONARY STENTING

New options in Stroke Prevention in AF Paul Dorian University of Toronto St Michael s Hospital

Dual antiplatelet therapy (DAPT) in the era of Novel Oral Anticoagulants (NOACs) SACIS 2015

Treatment with Apixaban Eliquis

Study design: multicenter, randomized, open-label trial following a PROBE design

ESC Congress 2012, Munich

Lessons from recent antithrombotic studies and trials in atrial fibrillation

Antiplatelet Therapy in Patients on Anticoagulation

A Patient Unsuitable for VKA Treatment

Joshua D. Lenchus, DO, RPh, FACP, SFHM Associate Professor of Medicine and Anesthesiology University of Miami Miller School of Medicine

Dr Αντώνιος Στ. Ντάτσιος MSc, MRCP(UK), FESC. Επεμβατικός Καρδιολόγος Επιμελητής Β Γ. Ν. Θ. Παπαγεωργίου

A Patient with Chest Pain and Atrial Fibrillation

Eliquis effect on inr prolongation 2017

Clinical and Economic Value of Rivaroxaban in Coronary Artery Disease

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Anticoagulation Management Around Endoscopy: GI Perspective. Nathan Landesman, DO FACOI Flint Gastroenterology Associates October 11, 2017

Treatment with Rivaroxaban Xarelto

Secondary Stroke Prevention: A Precautionary Tale

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)

Pros and Cons of Individual Agents Based on Large Trial Results: RELY, ROCKET, ARISTOTLE, AVERROES

Aspirin at the Intersection of Antiplatelet and Anticoagulant Therapy An Act of Commission?

Drug Class Review Newer Oral Anticoagulant Drugs

Xarelto (rivaroxaban)

Aspirin versus pradaxa

Let s Gi e The So ethi g To Clot About: Controversies in Anticoagulation

ANTI-THROMBOTIC THERAPY in NON-VALVULAR ATRIAL FIBRILLATION

Apixaban for stroke prevention in atrial fibrillation. August 2010

Pradaxa (dabigatran)

NOACs in AF. Dr Colin Edwards Auckland Heart Group and Waitemata DHB. Dr Fiona Stewart Auckland Heart Group and Auckland DHB

Updates in Stroke Management. Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy

North Wales Cardiac Network Guidelines on oral antiplatelet therapy in cardiovascular disease

A New Era for NOACs: What Does the Future Hold? CME

Bayer s Rivaroxaban Demonstrated Superior Protection Against Recurrent Venous Thromboembolism Compared with Aspirin in EINSTEIN CHOICE Study

News Release. For UK Media

Afib, Stroke, and DOAC. Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS

New Study Presented at American Heart Association (AHA) Scientific Sessions 2016:

DISCLOSURE. What I am Talking About. Rational Use of Antiplatelet Agents. Aspirin. Tom DeLoughery, MD MACP FAWM

Pharmacologic Agents to Prevent Stroke in Non-Valvular Atrial Fibrillation and PFO

American College of Cardiology 66th Annual Scientific Session (ACC.17):

NeuroPI Case Study: Anticoagulant Therapy

Plavix duration of effect

Update on the NOAC s: 2018 Daniel Blanchard, MD, FACC, FAHA

Antithrombotics in the elderly. Robert Gabor Kiss FESC FACC Budapest

Anticoagulants and antiplatelet therapy in the older patient: Choosing wisely

Byeong-Keuk Kim, M.D. Ph D. Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Medicine, Seoul, Korea

Disclosure Slide. Controversies in Anticoagulation. Presenter Disclosure Information. Challenges in Anticoagulation

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

Στεφανιαίος ασθενής με μη βαλβιδική Κολπική Μαρμαρυγή - Νέες στρατηγικές

Paolo Gresele Dipartimento di Medicina Sezione di Medicina Interna e Cardiovascolare Università di Perugia

Robert C. Welsh, MD, FRCPC Professor of Medicine, University of Alberta Zone Clinical Department Head, Cardiac Sciences

Nanik Hatsakorzian Pharm.D/MPH

Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology

ADC Slides for Presentation 02/10/2017

After acute coronary syndromes patients continue to have recurrent ischemic events despite revascularization and dual antiplatelet therapy

Changing Course: Anticoagulation in Secondary Prevention of Cardiovascular Disease Events

Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University

Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH

Do s and Don t of DOACs DISCLOSURE

NOAC s across indications

Anticoagulants and Antiplatelet. Therapy

Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG:

HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation

Edoxaban in Atrial Fibrillation

A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

Apixaban for Atrial Fibrillation in Patients with End-Stage Renal Disease on Dialysis

New Aspects in the Diagnosis and Treatment of Atrial Fibrillation: Antithrombotic Therapy

What s new with DOACs? Defining place in therapy for edoxaban &

State of the Art in the ACS Atrial Fibrillation Overlap Syndrome

Patient with high risk for bleeding

Evaluate Risk of Stroke & Bleeding in AF Patients

Transcription:

Eliquis and plavix combination therapy ELIQUIS Dosing for Patients With NVAF. patients treated with aspirin or the combination of bleeding or completion of a course of therapy,. 9-11-2011 Thrombosis is a peer who are considered unsuitable for vitamin K antagonist therapy. However, the combination of aspirin and clopidogrel does. Correspondence from The New England Journal of Medicine Apixaban after Acute Coronary Syndrome. therapy in atrial fibrillation in combination with acute. Eliquis and plavix combination therapy -- Which is a huge statement I understand However for 16 minutes while preferred manual gears even. Plavix vs eliquis - Can I substitute Plavix (clopidogrel) for Eliquis? I have Atril fibrillation condition. What are advantages and disadvantages of each medication. Learn about drug interactions between apixaban oral and clopidogrel oral and use the RxList drug interaction checker to check drug combinations.. Eliquis Oral. All. Eliquis official prescribing post-acute coronary syndrome patients treated with aspirin or the combination of. (2.3%) use of dual antiplatelet therapy with. 17-3-2009 BackgroundApixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent ischemic events when added to antiplatelet therapy after an acute. 16-8-2013 Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events (ADANCE). Triple therapy with rivaroxaban, apixaban, or dabigatran etexilate combined with ASA and clopidogrel has been tested in patients with ACS to explore whether a prolonged anticoagulation could reduce the residual risk of thrombosis in patients with MI.,, Apixaban was added to ASA and clopidogrel in therapeutic doses (5. Feb 2, 2012. The ACTIVE-A trial (effect of clopidogrel added to aspirin in patients with atrial fibrillation) assessed the combined therapy of aspirin and clopidogrel in.. In conclusion, in patients who require dual or triple therapy, low-dose dabigatran or apixaban might be a good alternative to warfarin due to good efficacy. 110 mg BID, rivaroxaban 15 mg QD and apixaban 2.5 mg BID. *Dual therapy with oral anticoagulation and clopidogrel may be considered in selected patients. ** Aspirin as an alternative to clopidogrel may be considered in patients on dual therapy (i.e. oral anticoagulation plus single antiplatelet). ***Dual therapy with oral. Oct 18, 2013. Because of the increase in bleeding and the cumbersome management of vitamin K antagonists, such combination therapy has never gained much popularity. The recent development of new, non vitamin K antagonists, direct oral anticoagulants (NOACs), including dabigatran, apixaban, rivaroxaban, and. Using apixaban together with clopidogrel may increase the risk of bleeding, including severe and sometimes fatal hemorrhage. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken. Nov 10, 2011. Anticoagulation is the best antithrombotic therapy for the prevention of stroke in patients with atrial fibrillation, and apixaban seems a better option than warfarin by offering a lower risk of systemic embolism, less bleeding, and lower mortality. Combined therapy with aspirin and clopidogrel is less effective. Feb 1, 2018. Patients with coronary artery disease (CAD) with indications for long-term anticoagulant and antiplatelet therapy are a clinical challenge with regard to the ne.. In Europe, apixaban 2.5 mg twice daily is sometimes used with aspirin and clopidogrel. There is no evidence to support this strategy. Jul 24, 2011. The rates of the primary efficacy outcome among patients who were receiving combination

antiplatelet therapy were 7.2% in the apixaban group and 7.5% in. The current standard of care for patients after an acute coronary syndrome includes dual antiplatelet therapy, typically with aspirin and clopidogrel. Nov 21, 2011. Other ongoing randomized trials in this field are evaluating efficacy and safety of a combination of clopidogrel plus OAC as compared to triple therapy (WOEST, NCT00769938), or DAT with. Is a NEW-TRIPLE Therapy with Either Prasugrel/ Ticagrelor or Dabigatran/Rivaroxaban/Apixaban an Option?. A total of 384 drugs (1515 brand and generic names) are known to interact with Eliquis (apixaban). The classifications below are a general guideline only. It is. Please note: This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. Clinical Notes: For patients with atrial fibrillation (AF) and low risk of stroke, antithrombotic therapy is not recommended. 2; For patients with AF and either. When deciding what type of blood thinner is best, the question of Eliquis versus Warfarin often arises. Blood thinners, also called anticoagulants, are a class. Please note: This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. 272 medications are known to interact with Plavix. Includes amlodipine, aspirin, Aspirin Low Strength (aspirin). ARBs (Angiotensin Receptor Blockers) and ARB combinations; Tier 1. Tier 2. Tier 3. benazepril (Lotensin ) captopril (Capoten ) enalapril (Vasotec ) enalaprilat. Pictures of Eliquis (Apixaban Tablets), drug imprint information, side effects for the patient. The American College of Chest Physicians provides recommendations for the use of anticoagulant medications for several indications that are important in the primary. Learn about Eliquis (Apixaban Tablets) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Eliquis official prescribing post-acute coronary syndrome patients treated with aspirin or the combination of. (2.3%) use of dual antiplatelet therapy with. Eliquis and plavix combination therapy -- Which is a huge statement I understand However for 16 minutes while preferred manual gears even. 16-8-2013 Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events (ADANCE). ELIQUIS Dosing for Patients With NVAF. patients treated with aspirin or the combination of bleeding or completion of a course of therapy,. Plavix vs eliquis - Can I substitute Plavix (clopidogrel) for Eliquis? I have Atril fibrillation condition. What are advantages and disadvantages of each medication. Learn about drug interactions between apixaban oral and clopidogrel oral and use the RxList drug interaction checker to check drug combinations.. Eliquis Oral. All. 17-3-2009 BackgroundApixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent ischemic events when added to antiplatelet therapy after an acute. Correspondence from The New England Journal of Medicine Apixaban after Acute Coronary Syndrome. therapy in atrial fibrillation in combination with acute. 9-11-2011 Thrombosis is a peer who are considered unsuitable for vitamin K antagonist therapy. However, the combination of aspirin and clopidogrel does. Nov 10, 2011. Anticoagulation is the best antithrombotic therapy for the prevention of stroke in patients with atrial fibrillation, and apixaban seems a better option than warfarin by offering a lower risk of systemic embolism, less bleeding, and lower mortality. Combined therapy with aspirin and clopidogrel is less effective. 110 mg BID, rivaroxaban 15 mg QD and apixaban 2.5 mg BID. *Dual therapy with oral anticoagulation and clopidogrel may be considered in selected patients. ** Aspirin as an alternative to clopidogrel may be considered in patients on dual therapy (i.e. oral anticoagulation plus single antiplatelet). ***Dual therapy with oral. Feb 1, 2018. Patients with coronary artery disease (CAD) with indications for long-term anticoagulant and antiplatelet therapy are a clinical challenge with regard to the ne.. In

Europe, apixaban 2.5 mg twice daily is sometimes used with aspirin and clopidogrel. There is no evidence to support this strategy. Jul 24, 2011. The rates of the primary efficacy outcome among patients who were receiving combination antiplatelet therapy were 7.2% in the apixaban group and 7.5% in. The current standard of care for patients after an acute coronary syndrome includes dual antiplatelet therapy, typically with aspirin and clopidogrel. Feb 2, 2012. The ACTIVE-A trial (effect of clopidogrel added to aspirin in patients with atrial fibrillation) assessed the combined therapy of aspirin and clopidogrel in.. In conclusion, in patients who require dual or triple therapy, low-dose dabigatran or apixaban might be a good alternative to warfarin due to good efficacy. Oct 18, 2013. Because of the increase in bleeding and the cumbersome management of vitamin K antagonists, such combination therapy has never gained much popularity. The recent development of new, non vitamin K antagonists, direct oral anticoagulants (NOACs), including dabigatran, apixaban, rivaroxaban, and. Nov 21, 2011. Other ongoing randomized trials in this field are evaluating efficacy and safety of a combination of clopidogrel plus OAC as compared to triple therapy (WOEST, NCT00769938), or DAT with. Is a NEW-TRIPLE Therapy with Either Prasugrel/ Ticagrelor or Dabigatran/Rivaroxaban/Apixaban an Option?. Using apixaban together with clopidogrel may increase the risk of bleeding, including severe and sometimes fatal hemorrhage. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken. Triple therapy with rivaroxaban, apixaban, or dabigatran etexilate combined with ASA and clopidogrel has been tested in patients with ACS to explore whether a prolonged anticoagulation could reduce the residual risk of thrombosis in patients with MI.,, Apixaban was added to ASA and clopidogrel in therapeutic doses (5. The American College of Chest Physicians provides recommendations for the use of anticoagulant medications for several indications that are important in the primary. ARBs (Angiotensin Receptor Blockers) and ARB combinations; Tier 1. Tier 2. Tier 3. benazepril (Lotensin ) captopril (Capoten ) enalapril (Vasotec ) enalaprilat. Learn about Eliquis (Apixaban Tablets) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. When deciding what type of blood thinner is best, the question of Eliquis versus Warfarin often arises. Blood thinners, also called anticoagulants, are a class. Pictures of Eliquis (Apixaban Tablets), drug imprint information, side effects for the patient. Please note: This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. Please note: This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. A total of 384 drugs (1515 brand and generic names) are known to interact with Eliquis (apixaban). The classifications below are a general guideline only. It is. 272 medications are known to interact with Plavix. Includes amlodipine, aspirin, Aspirin Low Strength (aspirin). Clinical Notes: For patients with atrial fibrillation (AF) and low risk of stroke, antithrombotic therapy is not recommended. 2; For patients with AF and either. ELIQUIS Dosing for Patients With NVAF. patients treated with aspirin or the combination of bleeding or completion of a course of therapy,. 17-3-2009 BackgroundApixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent ischemic events when added to antiplatelet therapy after an acute. Plavix vs eliquis - Can I substitute Plavix (clopidogrel) for Eliquis? I have Atril fibrillation condition. What are advantages and disadvantages of each medication. 16-8-2013 Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events (ADANCE). Eliquis official

prescribing post-acute coronary syndrome patients treated with aspirin or the combination of. (2.3%) use of dual antiplatelet therapy with. Learn about drug interactions between apixaban oral and clopidogrel oral and use the RxList drug interaction checker to check drug combinations.. Eliquis Oral. All. Correspondence from The New England Journal of Medicine Apixaban after Acute Coronary Syndrome. therapy in atrial fibrillation in combination with acute. 9-11-2011 Thrombosis is a peer who are considered unsuitable for vitamin K antagonist therapy. However, the combination of aspirin and clopidogrel does. Eliquis and plavix combination therapy -- Which is a huge statement I understand However for 16 minutes while preferred manual gears even. Using apixaban together with clopidogrel may increase the risk of bleeding, including severe and sometimes fatal hemorrhage. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken. Oct 18, 2013. Because of the increase in bleeding and the cumbersome management of vitamin K antagonists, such combination therapy has never gained much popularity. The recent development of new, non vitamin K antagonists, direct oral anticoagulants (NOACs), including dabigatran, apixaban, rivaroxaban, and. Feb 2, 2012. The ACTIVE-A trial (effect of clopidogrel added to aspirin in patients with atrial fibrillation) assessed the combined therapy of aspirin and clopidogrel in.. In conclusion, in patients who require dual or triple therapy, low-dose dabigatran or apixaban might be a good alternative to warfarin due to good efficacy. Jul 24, 2011. The rates of the primary efficacy outcome among patients who were receiving combination antiplatelet therapy were 7.2% in the apixaban group and 7.5% in. The current standard of care for patients after an acute coronary syndrome includes dual antiplatelet therapy, typically with aspirin and clopidogrel. Triple therapy with rivaroxaban, apixaban, or dabigatran etexilate combined with ASA and clopidogrel has been tested in patients with ACS to explore whether a prolonged anticoagulation could reduce the residual risk of thrombosis in patients with MI.,, Apixaban was added to ASA and clopidogrel in therapeutic doses (5. Nov 21, 2011. Other ongoing randomized trials in this field are evaluating efficacy and safety of a combination of clopidogrel plus OAC as compared to triple therapy (WOEST, NCT00769938), or DAT with. Is a NEW-TRIPLE Therapy with Either Prasugrel/ Ticagrelor or Dabigatran/Rivaroxaban/Apixaban an Option?. Nov 10, 2011. Anticoagulation is the best antithrombotic therapy for the prevention of stroke in patients with atrial fibrillation, and apixaban seems a better option than warfarin by offering a lower risk of systemic embolism, less bleeding, and lower mortality. Combined therapy with aspirin and clopidogrel is less effective. Feb 1, 2018. Patients with coronary artery disease (CAD) with indications for long-term anticoagulant and antiplatelet therapy are a clinical challenge with regard to the ne.. In Europe, apixaban 2.5 mg twice daily is sometimes used with aspirin and clopidogrel. There is no evidence to support this strategy. 110 mg BID, rivaroxaban 15 mg QD and apixaban 2.5 mg BID. *Dual therapy with oral anticoagulation and clopidogrel may be considered in selected patients. ** Aspirin as an alternative to clopidogrel may be considered in patients on dual therapy (i.e. oral anticoagulation plus single antiplatelet). ***Dual therapy with oral. Please note: This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. When deciding what type of blood thinner is best, the question of Eliquis versus Warfarin often arises. Blood thinners, also called anticoagulants, are a class. ARBs (Angiotensin Receptor Blockers) and ARB combinations; Tier 1. Tier 2. Tier 3. benazepril (Lotensin ) captopril (Capoten ) enalapril (Vasotec ) enalaprilat. Please note: This list represents brand products in CAPS, branded

generics in upper- and lowercase Italics, and generic products in lowercase italics. Clinical Notes: For patients with atrial fibrillation (AF) and low risk of stroke, antithrombotic therapy is not recommended. 2; For patients with AF and either. The American College of Chest Physicians provides recommendations for the use of anticoagulant medications for several indications that are important in the primary. Pictures of Eliquis (Apixaban Tablets), drug imprint information, side effects for the patient. Learn about Eliquis (Apixaban Tablets) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. A total of 384 drugs (1515 brand and generic names) are known to interact with Eliquis (apixaban). The classifications below are a general guideline only. It is. 272 medications are known to interact with Plavix. Includes amlodipine, aspirin, Aspirin Low Strength (aspirin).